Review



insulin human inhalation powder  (Pfizer Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Pfizer Inc insulin human inhalation powder
    Insulin Human Inhalation Powder, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/insulin+human+inhalation+powder/pmc12641079-33-22-13?v=Pfizer+Inc
    Average 86 stars, based on 1 article reviews
    insulin human inhalation powder - by Bioz Stars, 2026-07
    86/100 stars

    Images



    Similar Products

    insulin human inhalation powder  (Pfizer Inc)
    86
    Pfizer Inc insulin human inhalation powder
    Insulin Human Inhalation Powder, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/insulin+human+inhalation+powder/pmc12641079-33-22-13?v=Pfizer+Inc
    Average 86 stars, based on 1 article reviews
    insulin human inhalation powder - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    inhaled human insulin powder exubera  (Pfizer Inc)
    90
    Pfizer Inc inhaled human insulin powder exubera
    Inhaled Human Insulin Powder Exubera, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/insulin+human+inhalation+powder/pm37385962-302-2-6?v=Pfizer+Inc
    Average 90 stars, based on 1 article reviews
    inhaled human insulin powder exubera - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    inhaled, rapid-acting, dry-powder formulation of recombinant human insulin  (Mannkind Inc)
    90
    Mannkind Inc inhaled, rapid-acting, dry-powder formulation of recombinant human insulin
    Inhaled, Rapid Acting, Dry Powder Formulation Of Recombinant Human Insulin, supplied by Mannkind Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/insulin+human+inhalation+powder/pm34664212-124-11-18?v=Mannkind+Inc
    Average 90 stars, based on 1 article reviews
    inhaled, rapid-acting, dry-powder formulation of recombinant human insulin - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    afrezza® (human insulin) inhalation powder  (Mannkind Inc)
    90
    Mannkind Inc afrezza® (human insulin) inhalation powder
    Afrezza® (Human Insulin) Inhalation Powder, supplied by Mannkind Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/insulin+human+inhalation+powder/pm32325175-32-1-8?v=Mannkind+Inc
    Average 90 stars, based on 1 article reviews
    afrezza® (human insulin) inhalation powder - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    afrezza® (insulin human) inhalation powder  (Mannkind Inc)
    90
    Mannkind Inc afrezza® (insulin human) inhalation powder
    Afrezza® (Insulin Human) Inhalation Powder, supplied by Mannkind Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/insulin+human+inhalation+powder/pm32325175-61-3-20?v=Mannkind+Inc
    Average 90 stars, based on 1 article reviews
    afrezza® (insulin human) inhalation powder - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    insulin human inhalation powder afreeza  (Mannkind Inc)
    90
    Mannkind Inc insulin human inhalation powder afreeza
    Insulin Human Inhalation Powder Afreeza, supplied by Mannkind Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/insulin+human+inhalation+powder/pmc06986815-315-2-7?v=Mannkind+Inc
    Average 90 stars, based on 1 article reviews
    insulin human inhalation powder afreeza - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    exubera® insulin human [rdna origin] inhalation powder  (Pfizer Inc)
    90
    Pfizer Inc exubera® insulin human [rdna origin] inhalation powder
    Baseline demographic and clinical characteristics.
    Exubera® Insulin Human [Rdna Origin] Inhalation Powder, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/insulin+human+inhalation+powder/pmc07251384-78-0-16?v=Pfizer+Inc
    Average 90 stars, based on 1 article reviews
    exubera® insulin human [rdna origin] inhalation powder - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    exubera® insulin human [rdna origin] inhalation powder  (Sanofi)
    90
    Sanofi exubera® insulin human [rdna origin] inhalation powder
    Baseline demographic and clinical characteristics.
    Exubera® Insulin Human [Rdna Origin] Inhalation Powder, supplied by Sanofi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/insulin+human+inhalation+powder/pmc07251384-78-0-20?v=Sanofi
    Average 90 stars, based on 1 article reviews
    exubera® insulin human [rdna origin] inhalation powder - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    exubera® insulin human [rdna origin] inhalation powder  (Nektar Inc)
    90
    Nektar Inc exubera® insulin human [rdna origin] inhalation powder
    Baseline demographic and clinical characteristics.
    Exubera® Insulin Human [Rdna Origin] Inhalation Powder, supplied by Nektar Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/insulin+human+inhalation+powder/pmc07251384-78-0-22?v=Nektar+Inc
    Average 90 stars, based on 1 article reviews
    exubera® insulin human [rdna origin] inhalation powder - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Baseline demographic and clinical characteristics.

    Journal: Contemporary Clinical Trials Communications

    Article Title: Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME)

    doi: 10.1016/j.conctc.2019.100427

    Figure Lengend Snippet: Baseline demographic and clinical characteristics.

    Article Snippet: Exubera® insulin human [rDNA origin] Inhalation Powder (EXU) is an inhaled rapid-acting human insulin developed by Pfizer in collaboration with Sanofi-Aventis and Nektar Therapeutics to control hyperglycemia in adult patients with type 1 and 2 diabetes It was intended to provide a non-invasive alternative to subcutaneously (SC) injected short-acting insulin [ ].

    Techniques:

    Summary of subjects experiencing a FEV 1 decline.

    Journal: Contemporary Clinical Trials Communications

    Article Title: Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME)

    doi: 10.1016/j.conctc.2019.100427

    Figure Lengend Snippet: Summary of subjects experiencing a FEV 1 decline.

    Article Snippet: Exubera® insulin human [rDNA origin] Inhalation Powder (EXU) is an inhaled rapid-acting human insulin developed by Pfizer in collaboration with Sanofi-Aventis and Nektar Therapeutics to control hyperglycemia in adult patients with type 1 and 2 diabetes It was intended to provide a non-invasive alternative to subcutaneously (SC) injected short-acting insulin [ ].

    Techniques:

    Pulmonary, cardiovascular, allergic reaction and all-cause mortality secondary endpoints.

    Journal: Contemporary Clinical Trials Communications

    Article Title: Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME)

    doi: 10.1016/j.conctc.2019.100427

    Figure Lengend Snippet: Pulmonary, cardiovascular, allergic reaction and all-cause mortality secondary endpoints.

    Article Snippet: Exubera® insulin human [rDNA origin] Inhalation Powder (EXU) is an inhaled rapid-acting human insulin developed by Pfizer in collaboration with Sanofi-Aventis and Nektar Therapeutics to control hyperglycemia in adult patients with type 1 and 2 diabetes It was intended to provide a non-invasive alternative to subcutaneously (SC) injected short-acting insulin [ ].

    Techniques:

    Baseline demographic and clinical characteristics.

    Journal: Contemporary Clinical Trials Communications

    Article Title: Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME)

    doi: 10.1016/j.conctc.2019.100427

    Figure Lengend Snippet: Baseline demographic and clinical characteristics.

    Article Snippet: Exubera® insulin human [rDNA origin] Inhalation Powder (EXU) is an inhaled rapid-acting human insulin developed by Pfizer in collaboration with Sanofi-Aventis and Nektar Therapeutics to control hyperglycemia in adult patients with type 1 and 2 diabetes It was intended to provide a non-invasive alternative to subcutaneously (SC) injected short-acting insulin [ ].

    Techniques:

    Summary of subjects experiencing a FEV 1 decline.

    Journal: Contemporary Clinical Trials Communications

    Article Title: Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME)

    doi: 10.1016/j.conctc.2019.100427

    Figure Lengend Snippet: Summary of subjects experiencing a FEV 1 decline.

    Article Snippet: Exubera® insulin human [rDNA origin] Inhalation Powder (EXU) is an inhaled rapid-acting human insulin developed by Pfizer in collaboration with Sanofi-Aventis and Nektar Therapeutics to control hyperglycemia in adult patients with type 1 and 2 diabetes It was intended to provide a non-invasive alternative to subcutaneously (SC) injected short-acting insulin [ ].

    Techniques:

    Pulmonary, cardiovascular, allergic reaction and all-cause mortality secondary endpoints.

    Journal: Contemporary Clinical Trials Communications

    Article Title: Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME)

    doi: 10.1016/j.conctc.2019.100427

    Figure Lengend Snippet: Pulmonary, cardiovascular, allergic reaction and all-cause mortality secondary endpoints.

    Article Snippet: Exubera® insulin human [rDNA origin] Inhalation Powder (EXU) is an inhaled rapid-acting human insulin developed by Pfizer in collaboration with Sanofi-Aventis and Nektar Therapeutics to control hyperglycemia in adult patients with type 1 and 2 diabetes It was intended to provide a non-invasive alternative to subcutaneously (SC) injected short-acting insulin [ ].

    Techniques:

    Baseline demographic and clinical characteristics.

    Journal: Contemporary Clinical Trials Communications

    Article Title: Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME)

    doi: 10.1016/j.conctc.2019.100427

    Figure Lengend Snippet: Baseline demographic and clinical characteristics.

    Article Snippet: Exubera® insulin human [rDNA origin] Inhalation Powder (EXU) is an inhaled rapid-acting human insulin developed by Pfizer in collaboration with Sanofi-Aventis and Nektar Therapeutics to control hyperglycemia in adult patients with type 1 and 2 diabetes It was intended to provide a non-invasive alternative to subcutaneously (SC) injected short-acting insulin [ ].

    Techniques:

    Summary of subjects experiencing a FEV 1 decline.

    Journal: Contemporary Clinical Trials Communications

    Article Title: Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME)

    doi: 10.1016/j.conctc.2019.100427

    Figure Lengend Snippet: Summary of subjects experiencing a FEV 1 decline.

    Article Snippet: Exubera® insulin human [rDNA origin] Inhalation Powder (EXU) is an inhaled rapid-acting human insulin developed by Pfizer in collaboration with Sanofi-Aventis and Nektar Therapeutics to control hyperglycemia in adult patients with type 1 and 2 diabetes It was intended to provide a non-invasive alternative to subcutaneously (SC) injected short-acting insulin [ ].

    Techniques:

    Pulmonary, cardiovascular, allergic reaction and all-cause mortality secondary endpoints.

    Journal: Contemporary Clinical Trials Communications

    Article Title: Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME)

    doi: 10.1016/j.conctc.2019.100427

    Figure Lengend Snippet: Pulmonary, cardiovascular, allergic reaction and all-cause mortality secondary endpoints.

    Article Snippet: Exubera® insulin human [rDNA origin] Inhalation Powder (EXU) is an inhaled rapid-acting human insulin developed by Pfizer in collaboration with Sanofi-Aventis and Nektar Therapeutics to control hyperglycemia in adult patients with type 1 and 2 diabetes It was intended to provide a non-invasive alternative to subcutaneously (SC) injected short-acting insulin [ ].

    Techniques: